Very interesting study here on the placebo effect, showing that it can still have an impact even when participants are told they're being given the placebo! Important implications for veterinary research where placebo's or controls are lacking https://t.co/8bvHhIc5Pa
Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Feb 2019 – Jun 2024Where it's discussed
-
X / Twitter4 posts
-
YouTube2 videos
AI synopsis
What people are saying
The discussions reflect curiosity and support for the study, with remarks such as the 2008 placebo research and its relevance to mainstream treatment, and emphasizing the potential for significant practice changes. The tone suggests engagement with the scientific implications, especially considering the surprising effectiveness of open-label placebos and their broader applications.
Most discussions recognize the significance of the study, with some referencing prior research and its implications, indicating general support.
Participants show high curiosity about the study, referencing past studies and considering broader applications.
Comments discuss specifics like the effectiveness of open-label placebos and implications for different fields, demonstrating active involvement.
The discussions highlight the potential influence of the findings on medical and veterinary practices, indicating a moderate perceived impact.
Abstract in brief
- The study compares open-label placebo (OLP), where patients know they're getting a placebo, with double-blind placebo (DBP), where neither patients nor researchers know who is getting the placebo, in treating irritable bowel syndrome (IBS).
- Recent research shows that even when patients know they're taking a placebo (OLP), they can still experience symptom relief, challenging traditional beliefs about placebo effects.
- The study also aims to identify genetic and psychological factors that predict OLP responses and explores patients' personal experiences through interviews, potentially reshaping how healthcare providers use placebo effects ethically to improve symptom management.]
Top posts
Most liked on X and Bluesky@Spongecoinbob There was a study in 2008 on placebo treatments for IBS and it was SO effective that there was a follow-up study on using open-label placebos as a mainstream treatment (literally telling people it's a placebo). https://t.co/HNDDwj6ZGD You have done zero research, clearly.
Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial. - PubMed - NCBI https://t.co/91uLPJDTZk
@ashtroid22 You have probably already read this, still pretty good. @r_bsal, do you have any thoughts on this? https://t.co/LNRUDomBKn
All mentions
Effect of Magnesium Glycinate on Sleep: Results of a Controlled Trial
This video explores whether magnesium glycinate improves sleep quality, based on a placebo-controlled trial involving 300mg nightly. We examine the findings and discuss the potential benefits of magnesium…
Exploring the Efficacy of Placebos in Treating IBS Symptoms
This video discusses the fascinating role of placebo effects in health outcomes, highlighting recent research comparing open-label and double-blind placebo treatments for irritable bowel syndrome, and how patient…
@ashtroid22 You have probably already read this, still pretty good. @r_bsal, do you have any thoughts on this? https://t.co/LNRUDomBKn
@Spongecoinbob There was a study in 2008 on placebo treatments for IBS and it was SO effective that there was a follow-up study on using open-label placebos as a mainstream treatment (literally telling people it's a placebo). https://t.co/HNDDwj6ZGD You have done zero research, clearly.
Very interesting study here on the placebo effect, showing that it can still have an impact even when participants are told they're being given the placebo! Important implications for veterinary research where placebo's or controls are lacking https://t.co/8bvHhIc5Pa
Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial. - PubMed - NCBI https://t.co/91uLPJDTZk
NW
J
青
Q